These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23553276)

  • 1. Treatment for hepatitis C virus-induced portal hypertension in leukemic children.
    El-Ashry R; Malek HA; Ghayaty EA; El-Gendy AA; Darwish A; Al-Tonbary Y
    Med Oncol; 2013; 30(2):559. PubMed ID: 23553276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of combination antiviral therapy in chronic hepatitis C virus infection during therapy of acute lymphoblastic leukemia.
    Ayyub M; El-Moursy SA; Al-Abbas F
    Saudi J Gastroenterol; 2011; 17(4):283-6. PubMed ID: 21727738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Mahoney DH; Camitta BM; Leventhal BG; Shuster JJ; Civin CJ; Ganick DJ; Lauer SJ; Steuber CP; Kamen BA
    Cancer; 1995 May; 75(10):2623-31. PubMed ID: 7736409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic dysfunction in children with acute lymphoblastic leukemia in remission: relation to hepatitis infection.
    Meir H; Balawi I; Nayel H; El Karaksy H; El Haddad A
    Med Pediatr Oncol; 2001 Apr; 36(4):469-73. PubMed ID: 11260570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver function studies in children with acute lymphocytic leukemia after cessation of therapy.
    Bessho F; Kinumaki H; Yokota S; Hayashi Y; Kobayashi M; Kamoshita S
    Med Pediatr Oncol; 1994; 23(2):111-5. PubMed ID: 8202032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Combined Presence of Hepatitis C Virus and Polymorphisms in Different Genes With Toxicities of Methotrexate and 6-Mercaptopurine in Children With Acute Lymphoblastic Leukemia.
    Abdelaziz DH; Elhosseiny NM; Khaleel SA; Sabry NA; Attia AS; El-Sayed MH
    Pediatr Blood Cancer; 2016 Sep; 63(9):1539-45. PubMed ID: 27163515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study.
    Balis FM; Holcenberg JS; Poplack DG; Ge J; Sather HN; Murphy RF; Ames MM; Waskerwitz MJ; Tubergen DG; Zimm S; Gilchrist GS; Bleyer WA
    Blood; 1998 Nov; 92(10):3569-77. PubMed ID: 9808549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clotting abnormalities in children during maintenance chemotherapy for acute lymphoblastic leukemia.
    Aricò M; Gamba G; Raiteri E; Montani N; De Amici M; Burgio GR
    Haematologica; 1991; 76(6):472-4. PubMed ID: 1820983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune reconstitution during maintenance therapy in children with acute lymphoblastic leukemia, relation to co-existing infection.
    El-Chennawi FA; Al-Tonbary YA; Mossad YM; Ahmed MA
    Hematology; 2008 Aug; 13(4):203-9. PubMed ID: 18796245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of prolonged amlodipine treatment in hypertensive children.
    Flynn JT
    Pediatr Nephrol; 2005 May; 20(5):631-5. PubMed ID: 15785942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediate-dose methotrexate and intravenous 6-mercaptopurine chemotherapy for children with acute lymphoblastic leukemia who did not respond to initial induction therapy.
    Ogden AK; Pollock BH; Bernstein ML; Camitta B; Buchanan GR
    J Pediatr Hematol Oncol; 2002; 24(3):182-7. PubMed ID: 11990303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection in acute leukemia with liver dysfunction.
    Kawatani T; Suou T; Tajima F; Ooi S; Kawasaki H
    Eur J Haematol; 1993 Oct; 51(4):254-5. PubMed ID: 7694873
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial.
    Stork LC; Matloub Y; Broxson E; La M; Yanofsky R; Sather H; Hutchinson R; Heerema NA; Sorrell AD; Masterson M; Bleyer A; Gaynon PS
    Blood; 2010 Apr; 115(14):2740-8. PubMed ID: 20124218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign intracranial hypertension in association with acute lymphoblastic leukemia.
    Sastry J; Karandikar SS; English MW
    Pediatr Hematol Oncol; 2003 Mar; 20(2):157-60. PubMed ID: 12554527
    [No Abstract]   [Full Text] [Related]  

  • 15. Myelotoxicity, pharmacokinetics, and relapse rate with methotrexate/6-mercaptopurine maintenance therapy of childhood acute lymphoblastic leukemia.
    Schmiegelow K; Ifversen M
    Pediatr Hematol Oncol; 1996; 13(5):433-41. PubMed ID: 10897815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of hypertension in children presenting with acute lymphoblastic leukemia.
    Attard-Montalto SP; Saha V; Ng YY; Kingston JE; Eden OB
    Pediatr Hematol Oncol; 1994; 11(5):519-25. PubMed ID: 7826847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study.
    Schepis F; Vukotic R; Berzigotti A; Carrión JA; Forns X; Abraldes JG; García-Valdecasas JC; Navasa M; García-Pagán JC; Bosch J
    Liver Transpl; 2013 Apr; 19(4):450-6. PubMed ID: 23408436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia.
    Relling MV; Hancock ML; Boyett JM; Pui CH; Evans WE
    Blood; 1999 May; 93(9):2817-23. PubMed ID: 10216075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone.
    Waber DP; Carpentieri SC; Klar N; Silverman LB; Schwenn M; Hurwitz CA; Mullenix PJ; Tarbell NJ; Sallan SE
    J Pediatr Hematol Oncol; 2000; 22(3):206-13. PubMed ID: 10864051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
    Schmiegelow K; Heyman M; Kristinsson J; Mogensen UB; Rosthøj S; Vettenranta K; Wesenberg F; Saarinen-Pihkala U;
    J Pediatr Hematol Oncol; 2009 Jun; 31(6):385-92. PubMed ID: 19648786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.